Francesca Polverino, MD, PHD

Francesca Polverino, MD, PhD, is a physician-scientist and tenured Lester and Sue Smith Professor of Medicine at the Baylor College of Medicine.

Articles by Francesca Polverino, MD, PHD

Experts Say Early COPD Detection Is Key to Better Outcomes

ByAshley Gallagher, MA,Francesca Polverino, MD, PHD, Emily Wan, MD,David Halpin, MA, DPhil,Jadwiga A. Wedzicha, MD,Àlvar Agustí, MD, PhD

November 7th 2026

Àlvar Agustí, MD PhD; Jadwiga A. Wedzicha, MD; and 3 other experts say earlier diagnosis and intervention could most improve COPD outcomes within 5 years.

Anti–IL-33 Biologics in COPD: Francesca Polverino, MD, PhD

ByAshley Gallagher, MA,Francesca Polverino, MD, PHD

November 6th 2026

Baylor College of Medicine’s Francesca Polverino, MD, PhD, discusses interleukin-33 and mucus plugging.

Why ERS Congress Matters for Respiratory Care Clinicians

BySabrina McCrear,Jorgen Vestbo, MD,Francesca Polverino, MD, PHD,Francesca Puggioni, MD,Frank Sciurba, MD

September 17th 2026

Experts at ERS Congress 2026 discuss why attending respiratory conferences drives learning, networking, and better patient outcomes.

COPD Precision Medicine Still Lags: Francesca Polverino, MD, PhD

BySabrina McCrear,Francesca Polverino, MD, PHD

September 15th 2026

Francesca Polverino, MD, PhD, says COPD care still lacks a true precision medicine approach.

Beyond Eosinophils: COPD Biomarkers and Overtreatment Risk

BySabrina McCrear,Francesca Polverino, MD, PHD

September 14th 2026

Francesca Polverino, MD, PhD, discusses COPD biomarkers, patient susceptibility, overtreatment risk, and the future of risk stratification.

GOLD's COPD Escalation Rule Draws Debate: Francesca Polverino, MD, PhD

BySabrina McCrear,Francesca Polverino, MD, PHD

September 11th 2026

Francesca Polverino, MD, PhD, says COPD exacerbation severity lacks a clear definition, complicating GOLD's escalation criteria.

Francesca Polverino, MD, PHD

Articles by Francesca Polverino, MD, PHD

Experts Say Early COPD Detection Is Key to Better Outcomes

Anti–IL-33 Biologics in COPD: Francesca Polverino, MD, PhD

Why ERS Congress Matters for Respiratory Care Clinicians

COPD Precision Medicine Still Lags: Francesca Polverino, MD, PhD

Beyond Eosinophils: COPD Biomarkers and Overtreatment Risk

GOLD's COPD Escalation Rule Draws Debate: Francesca Polverino, MD, PhD

Latest Updated Articles

Trending on AJMC

Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic

AHIP's Jeanette Thornton on Prior Authorization Reform, Midterms

Study Finds Possible Deep Endometriosis in 7% of Postmenopausal Women

US Measles Outbreaks Cost Nearly $83 Million in 2026

Early-Onset Cancers Often Found Late as Screening Gaps Persist